Valneva is a specialty vaccine company providing prevention against diseases with major unmet medical needs. The Company has a growing commercial business with two successful vaccines for travelers. Our focused pipeline includes the only Lyme disease vaccine candidate in clinical development today and the only single-shot chikungunya vaccine candidate.

Valneva at a glance

Successful commercial vaccines for travelers

€m

Product sales revenues in 2019

Unique late stage vaccine programs

Specialized

Travel vaccines

Vector-transmitted diseases

Focused

On prevention against diseases with major medical needs

> 500

employees in six countries